[Update in the management of persistent pulmonary hypertension of the newborn]. / Actualités thérapeutiques dans l'hypertension artérielle pulmonaire persistante du nouveau-né.

ABSTRACT

Persistent pulmonary hypertension of the newborn is a severe disease leading to persistent and refractory hypoxemia with bad outcomes. The introduction of inhaled nitric oxide therapy significantly improved short and long term prognosis of those infants. More recently, sildenafil also appeared promising, but regimen and indications still need to be delineated.